Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Sara’s Cure



Email Address

[email protected]

Description

Sara’s Cure is a grass roots, race-against-time campaign focused on funding critical research to find a cure for Clear Cell Sarcoma. This non-profit 501(c)3 cause came to exist when 17 year old Sara Woods was diagnosed in 2016. Funds that Sara’s Cure raises will go to research and drug development for this cure. We are working directly with researchers and scientist at several top hospitals and labs. Since starting this cause we have connected with several other young patients who have joined our fight and naturally moved our mission into patient advocacy along with our original focus to find a cure. Facebook: https://www.facebook.com/sarascure/ Twitter: https://twitter.com/cure_saraUSA

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.